Market News AIOpen the app

INBX stock news · Inhibrx Biosciences, Inc.

Stories about Inhibrx Biosciences, Inc. (INBX) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for INBX

Follow Inhibrx Biosciences, Inc. (INBX) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for INBX
Free on the App Store and Google Play, or on the web.
  1. Nov 13, 2026, 4:17 PM ET · Market

    Inhibrx Biosciences shared its third-quarter results, showing a loss and revenue from a deal with Pfizer.

    Neutral

    INBX reported a $38.7 million quarterly loss, up from $35.3 million, and had $199.5 million in cash. Clinical progress and higher costs point in different directions, so the report does not change its outlook.